Commonly used cancer drugs boost MRSA antibiotics – new research shows
Scientists from University of Galway have uncovered a surprising link between commonly used anti-cancer drugs and antibiotics that…
Herself battling cancer, city woman helps fellow warriors with protein powder | Bhubaneswar News
Bhubaneswar: When Sangita Patnaik (55) was diagnosed with stage-II breast cancer in Dec 2024, her life went for…
How a 43-Year-Old Man With Colon Cancer Uses AI to Manage His Symptoms
Russ Read-Barrow has been living with incurable stage four colon cancer for five years. The 43-year-old former PR…
MD Anderson trial challenges local consolidative therapy paradigm in NSCLC
Adding local consolidative therapy (LCT) after induction treatment with nivolumab plus ipilimumab did not improve overall survival or…
Anti-cancer drugs may help treat MRSA – Irish study
Researchers find treatments helped penicillin-type antibiotics to kill the common hospital infection Four common chemotherapy drugs could help…
Psilocybin protects sensory nerves from chemotherapy damage in preclinical study
From mouse models to freshly isolated human nerves, researchers traced what happens when chemotherapy disrupts the cellular machinery…
Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Durvalumab Plus Chemotherapy in First-Line Advanced Biliary Tract Cancer in Single-Region Trial Conducted by Akeso in China
HARMONi-GI1 Conducted in China by Akeso Is First Known Phase III Study in Advanced BTC to Demonstrate OS…
New ‘smart cancer drug’ designed to ‘switch on’ may replace chemotherapy, says govt
In a major breakthrough for cancer treatment in India, the government on Thursday announced a “smart” cancer drug…
Colorectal tumors may damage nerves before chemotherapy
Researchers at The University of Texas MD Anderson Cancer Center found that, in preclinical models of colorectal cancer,…
Preoperative combination therapy improves head and neck cancer outcomes
Bottom line: Patients with head and neck cancer who received chemotherapy in addition to immunotherapy before surgery had…
New drug delivers promising survival gains in pancreatic cancer
About 90% of people with pancreatic cancer have pancreatic ductal adenocarcinoma (PDAC), which is driven by an activating mutation in…
Combination therapy overcomes ferroptosis resistance in β-catenin-mutant hepatocellular carcinoma
Background and aims The aberrant activation of the mTOR pathway and its crosstalk with other signaling cascades represent…